This novel specialty residency training program in Investigational Drugs and Research is an organized, directed postgraduate program to develop the knowledge, skills, and abilities required to support clinical drug research. The residency is designed to develop expert skills in a variety of settings that provide care for patients enrolled in clinical trials. The experience is designed to develop clinical, analytical, teaching, and leadership skills. Upon completion, the resident will be prepared for a position as an IDS pharmacist or other opportunities within clinical research.
Janet L. Mighty, BS Pharm, MBA, FASHP Director, Investigational Drug Service PGY1/PGY2 Investigational Drugs and Research Residency Program Director The Johns Hopkins Hospital 600 North Wolfe Street Carnegie 180 Baltimore, Maryland 21287-6180 Tel. 410-955-6337
From the 1889 opening of The Johns Hopkins Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.Today, Johns Hopkins uses one overarching name—Johns Hopkins Medicine—to identify its entire medical enterprise. This $6.7 billion system unites the physicians and scientists of the Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System.